← China Heal Plus

MEDICAL NEWS & POLICY

Healthcare updates

Medical news and healthcare policy from the United States, Europe and China, covering new treatments, research and access to specialist care.

Read the latest briefings below. Each includes publication dates and links to the original reports; older developments are identified as background.

FDA Approves Bepirovirsen for Selected Adults With Chronic Hepatitis B

The October 20 US decision includes defined laboratory criteria, use alongside existing antivirals and important safety monitoring.

Read the update →

FDA Grants Accelerated Approval for a Biomarker-Defined Rectal Cancer Treatment

The October 19 US decision covers dostarlimab for a defined group of adults with locally advanced rectal cancer.

Read the update →

FDA Lists Traditional Approval for Keytruda’s TMB-High Cancer Indication

The FDA conversion table records October 16, 2026 for a specific tumor mutational burden-high indication, following accelerated approval in 2020.

Read the update →

EMA Confirms Refusal of Yartemlea After Re-examination

The October 15 committee opinion concerns a serious stem-cell transplant complication. EMA published its updated explanation on October 16.

Read the update →

EMA Recommends Rasonque for Advanced Pancreatic Cancer

The October 15 recommendation concerns previously treated metastatic pancreatic cancer. An EU committee opinion, US approval and local access are separate steps.

Read the update →

FDA Expands Anktiva Approval for Bladder Cancer

The US bladder cancer approval now includes high-grade papillary-only tumors. In China, officials set priorities for sharing medical imaging records.

Read the update →

EMA Publishes Ocrevus Liver Safety Update

A European safety communication highlights liver injury risks with the multiple sclerosis medicine and monitoring before and during treatment.

Read the update →

FDA Approves Pritelivir for Hard-to-Treat Herpes Infections

The October 9 US approval covers certain immunocompromised adults whose herpes simplex lesions have not responded to other antiviral therapies.

Read the update →

FDA Approves Atezolizumab Combination for Stage III dMMR Colon Cancer

The October 8 US approval covers a defined group after surgery. Other regulators participating in Project Orbis are still reviewing the application.

Read the update →

US Insurers Face New Rules on Healthcare Price Transparency

New US rules address insurers’ public pricing files and telephone cost estimates, with consumer-tool changes applying from 2027 plan years.

Read the update →

FDA Approves a New Maintenance Regimen for HER2-Positive Breast Cancer

The October 7 US approval of tucatinib with trastuzumab and pertuzumab for maintenance treatment after induction therapy in specified adults with advanced HER2-positive breast cancer.

Read the update →

FDA Approves Expandable Pediatric Heart Valve; EMA Plans Women’s Health Roadmap

The FDA’s October 1 pediatric heart valve approval and EMA’s September 30 announcement of a planned women’s health medicines roadmap.

Read the update →

Prepared by China Heal Plus. These briefings provide general information, not individual medical advice.

Research & reading briefs · Patient guides · Ask about a specialist review